Contractor
NOVARTIS FARMACEUTICA, S.A.
ESP / BARCELONA / 08013
Total awarded
€163M
Award notices won
23
Lots won
50
Last award
Jul 20, 2026
Awarded lots
| Lot | CPV | Contract nature | Award value | Estimated value | Place | Award criteria |
|---|---|---|---|---|---|---|
LOT-0001 / La contratación, mediante acuerdo marco con un único empresario, del suministro sucesivo del medicamento TISAGENLECLEUCEL | Antineoplastic agents | supplies | €55M | €55M | ESP / Santiago de Compostela | price / 100% |
LOT-0001 / Suministro sucesivo del medicamento ONASEMNOGEN ABEPARVOVEC | Other nervous system medicinal products | supplies | €32.2M | - | ESP | price; quality +3 |
LOT-0001 / La contratación, mediante acuerdo marco con un único empresario, del suministro sucesivo del medicamento ONASEMNOGEN ABEPARVOVEC | Antineoplastic agents | supplies | €32.2M | €32.2M | ESP / Santiago de Compostela | price / 100% |
LOT-0001 / Suministro de Asciminib (DOE) | Pharmaceutical products | supplies | €5.69M | - | - | price |
LOT-0001 / 1 - L1_OMALIZUMAB (DOE) | Pharmaceutical products | supplies | €4.69M | - | - | price |
LOT-0002 / Eltrombopag 25mg/50mg | Various medicinal products | supplies | €3.84M | €24M | ESP | price / 100% |
LOT-0005 / 5 - L5_SECUKINUMAB (DOE) | Pharmaceutical products | supplies | €3.71M | - | - | price |
LOT-0003 / 3 - L3_ELTROMBOPAG (DOE) | Pharmaceutical products | supplies | €3.04M | - | - | price |
LOT-0004 / 4 - L4_DABRAFENIB (DOE) | Pharmaceutical products | supplies | €2.77M | - | - | price |
LOT-0043 / Lote 43 - Fármacos exclusivos de NOVARTIS FARMACEUTICA S.A | Pharmaceutical products | supplies | €2.48M | €7.06M | ESP / Barcelona | price |
Show 40 more rows
LOT-0002 / 2 - L2_NILOTINIB (DOE) | Pharmaceutical products | supplies | €1.89M | - | - | price |
LOT-0006 / 6 - L6_PAZOPANIB (DOE) | Pharmaceutical products | supplies | €1.66M | - | - | price |
LOT-0001 / SUMINISTRO DEL MEDICAMENTO EXCLUSIVO: ZOLGENSMA. | Pharmaceutical products | supplies | €1.34M | - | ESP / Madrid | cost / 100% |
LOT-0000 / Suministro de medicamentos exclusivos de la empresa NOVARTIS FARMACEUTICA, S.A., con destino a los pacientes del INGESA en el Área Sanitaria de Melilla | Pharmaceutical products | supplies | €1.29M | - | ESP | price / 100% |
LOT-0000 / Suministro de Onasemnogene Abeparvovec (Zolgensma ®) para el Servicio de Farmacia del Hospital Universitario Miguel Servet de Zaragoza | Pharmaceutical products | supplies | €1.28M | - | - | price / 100% |
LOT-0007 / 7 - L7_TRAMETINIB (DOE) | Pharmaceutical products | supplies | €1.21M | - | - | price |
LOT-0005 / Erenumab 140 mg pluma precargada subcutanea 1 ml | Various medicinal products | supplies | €987,878 | €2.17M | ESP | price / 100% |
LOT-0001 / Canakimumab 150mg/ml solución inyectable | Various medicinal products | supplies | €714,285 | €4.46M | ESP | price / 100% |
LOT-0001 / CBAM 2º NOVARTIS FARMACEÚTICA, S.A. CC AM 376/2025 | Pharmaceutical products | supplies | €500,000 | €480,769 | ESP | price |
LOT-0000 / suministro del medicamento SCEMBLIX 40 mg. comprimidos recubiertos con película – 60 comprimidos (principio activo ASCIMINIB), REVOLADE 25 MG. polvo para suspensión oral – 30 sobres (principio activo ELTROMBOPAG), KESIMPTA 20 MG. solución inyectable en pluma A PRECARGADA de 0,4 ML. (principio activo OFATUMUMAB), con destino Servicio de Farmacia del HUNSC | Various medicinal products | supplies | €496,857 | - | - | price / 100% |
LOT-0000 / Suministro de los medicamentos ILARIS 150 MG./ML solución inyectable, 1 VIAL DE 1 ML (principio activo CANAKINUMAB), TAFINLAR 50 MG. cápsulas duras 28 cápsulas (principio DABRAFENIB), COSENTYX 75 MG. SOL. INYECTABLE JER. PRECARGADA (principio activo SECUKINUMAB), con destino el Servicio de Farmacia del Hospital Universitario Ntra. Sra. de Candelaria. | Various medicinal products | supplies | €492,671 | - | - | price / 100% |
LOT-0003 / Trametinib 0,5mg/2mg. | Various medicinal products | supplies | €491,042 | €3.07M | ESP | price / 100% |
LOT-0004 / Pazopanib 400mg. | Various medicinal products | supplies | €447,943 | €2.8M | ESP | price / 100% |
LOT-0010 / Brolucizumab 120 mg/ml jeringa precargada 0,165 ml (19,8 mg) intravitrea | Various medicinal products | supplies | €395,220 | €869,484 | ESP | price / 100% |
LOT-0004 / Erenumab 70 mg pluma precargada subcutanea 1 ml | Various medicinal products | supplies | €378,451 | €832,592 | ESP | price / 100% |
LOT-0004 / 4 - KISQALI | Pharmaceutical products | supplies | €374,976 | €374,976 | ESP / Logroño | price / 100% |
LOT-0007 / Alpelisib 150 mg comprimidos oral | Various medicinal products | supplies | €341,258 | €750,768 | ESP | price / 100% |
LOT-0000 / Suministro del medicamento KYMRIAH (tisagenlecleucel). "Emergencia" | Pharmaceutical products | supplies | €319,488 | - | - | quality / 10% |
LOT-0002 / 2 - ILARIS | Pharmaceutical products | supplies | €305,250 | €305,250 | ESP / Logroño | price / 100% |
LOT-0006 / Siponimod 2 mg comprimidos oral | Various medicinal products | supplies | €284,175 | €625,186 | ESP | price / 100% |
LOT-0002 / Medicamento Inclisirán | Various medicinal products | supplies | €279,387 | €335,264 | ESP | price / 100% |
LOT-0009 / Alpelisib 50 mg + 200 mg comp oral | Various medicinal products | supplies | €189,588 | €417,094 | ESP | price / 100% |
LOT-0000 / Suministro del principio activo Gozetotida 25 microgramos, equipo reactivo para preparación radio farmacéutica, con destino al Servicio de Medicina Nuclear del Complejo Hospitalario Universitario Insular Materno Infantil de Gran Canaria | Isotopic reagents | supplies | €182,700 | - | ESP | price / 100% |
LOT-0000 / Suministro farmacéutico del principio activo Asciminib 40 mg y Asciminib 20 mg. | Pharmaceutical products | supplies | €169,630 | - | ESP | price / 100% |
LOT-0007 / 7 -TAFINLAR | Pharmaceutical products | supplies | €156,000 | €156,000 | ESP / Logroño | price / 100% |
LOT-0009 / 9 - L9_MIDOSTAURINA (DOE) | Pharmaceutical products | supplies | €153,764 | - | - | price |
LOT-0001 / 1 - AIMOVIG | Pharmaceutical products | supplies | €108,586 | €109,032 | ESP / Logroño | price / 100% |
LOT-0008 / Alpelisib 200 mg comprimidos oral | Various medicinal products | supplies | €104,273 | €229,401 | ESP | price / 100% |
LOT-0001 / SUMINISTRO DE MEDICAMENTOS EXCLUSIVOS: ERENUMAB (AIMOVIG), BACLOFENO (LIORESAL INTRATECAL), OCTEOTRIDO IM (SANDOSTATIN LAR), EVEROLIMUS INMUNOSUPRESOR (CERTICAN), RIBOCICLIB (KISQALI) Y LAPATINIB (TYVERB) | Pharmaceutical products | supplies | €91,268 | - | ESP / Madrid | cost / 100% |
LOT-0005 / 5 - MEKINIST | Pharmaceutical products | supplies | €80,302 | €80,302 | ESP / Logroño | price / 100% |
LOT-0008 / 8 - L8_EVEROLIMUS (DOE) | Pharmaceutical products | supplies | €79,601 | - | - | price |
LOT-0003 / 3 - KESIMPTA | Pharmaceutical products | supplies | €76,425 | €76,425 | ESP / Logroño | price / 100% |
LOT-0004 / LOTE 5:MEDICAMENTOS ONCOLÓGICOS (I) | General anti-infectives for systemic use, vaccines, antineoplastic and immunodulating agents Antineoplastic and immunomodulating agents | supplies | €59,487 | €22M | ESP / Sabadell | cost / 60% |
LOT-0006 / 6 - RYDAPT | Pharmaceutical products | supplies | €36,587 | €36,590 | ESP / Logroño | price / 100% |
LOT-0001 / Suministro sucesivo del medicamento Onasemnogen Abeparvovec | Other nervous system medicinal products | supplies | - | €32.2M | - | cost |
LOT-0001 / TASIGNA 150MG 112 CÁPSULAS | Medical equipments, pharmaceuticals and personal care products | supplies | - | - | - | price |
LOT-0002 / TASIGNA 200MG 112 CÁPSULAS | Medical equipments, pharmaceuticals and personal care products | supplies | - | - | - | price |
LOT-0004 / KESIMPTA 20 MG 1 PLUMA | Medical equipments, pharmaceuticals and personal care products | supplies | - | - | - | price |
LOT-0005 / MAYZENT 1 MG 28 COMPRIMIDOS | Medical equipments, pharmaceuticals and personal care products | supplies | - | - | - | price |
LOT-0006 / VOTUBIA 10 MG 30 COMPRIMIDOS | Medical equipments, pharmaceuticals and personal care products | supplies | - | - | - | price |
Award tenders
Show 13 more rows
Company details
Identifiers
A08011074
Countries
ESP
Cities
BARCELONA
Post codes
08013
8013
Emails
CPV codes
Owner nationalities
ESP
Size
large
About this contractor
NOVARTIS FARMACEUTICA, S.A. is a contractor that has been awarded public procurement contracts published through official European procurement systems.
This profile summarizes publicly available procurement information, including awarded contract value, awarded lots, procurement history, countries of activity, CPV classifications, and recent contract awards.
FAQ
What information does this contractor profile contain?
This profile summarizes publicly available procurement information about the contractor, including awarded contract values, awarded lots, procurement history, CPV classifications, locations, and company details when available.
What does Total Awarded mean?
Total Awarded represents the total known value of awarded contracts associated with this contractor based on available procurement data.
Why can the awarded value differ from the total contract value?
A contractor may be awarded one or more lots within a procurement procedure. As a result, the contractor's awarded value may differ from the total value of the procurement notice.
What are Awarded Lots?
Awarded lots are individual parts of a procurement procedure that have been awarded to this contractor.
How often is this profile updated?
Contractor profiles are updated automatically when new procurement notices and contract award notices become available.
Why are some company details missing?
Contractor profiles are generated from publicly available procurement notices. Some information, such as contact details or company registration data, may not be available in every notice.
Understanding this contractor profile
This contractor profile is generated from publicly available procurement information published by contracting authorities.
The profile helps procurement professionals, suppliers, researchers, and journalists understand a contractor's participation in public procurement.
Information may include awarded contract values, awarded lots, procurement history, procurement categories (CPV), locations, and contracting authorities.